Phase II proof-of-concept study of dextromethadone in patients with neuropathic pain
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2015
At a glance
- Drugs Dextromethadone (Primary)
- Indications Neuropathic pain
- Focus Proof of concept; Therapeutic Use
- Sponsors Relmada Therapeutics
- 07 Dec 2015 According to a Relmada Therapeutics media release, this study is expected to start in first-half of 2016.
- 09 Dec 2014 Status changed from not stated to planning.
- 08 Dec 2014 New trial record